Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Shawgi Sukumaran"'
Autor:
M. Nazim Abbas, Myron Klevansky, Bogda Koczwara, Amitesh Chandra Roy, Shawgi Sukumaran, Sina Vatandoust, Christos Stelios Karapetis
Publikováno v:
Cancer Reports, Vol 5, Iss 3, Pp n/a-n/a (2022)
Abstract Background Nivolumab improves disease control and survival in advanced NSCLC in patients with good performance status (PS), but there is limited data on its efficacy in patients with poor PS. Aim Primary objective of the study was to evaluat
Externí odkaz:
https://doaj.org/article/780ffd93d8ec4f52b293d9ebe91990d5
Autor:
Hilary Laura Martin, Shahid Ullah, Nazim Abbas, Alex Scott‐Hoy, Ganessan Kichenadasse, Christos Stelios Karapetis, Amitesh Roy, Shawgi Sukumaran, David M Ross, Muhammad Adnan Khattak, Bogda Koczwara
Publikováno v:
Cancer Reports, Vol 4, Iss 3, Pp n/a-n/a (2021)
Abstract Background Chemotherapy can cause premature menopause which may result in adverse effects such as fertility loss, osteoporosis, cardiovascular disease and menopausal symptoms. It is thus very important that women are provided with accurate i
Externí odkaz:
https://doaj.org/article/f10b59e518164f45af49712da2dd44f0
Autor:
William Murray-Brown, Tom D Wilsdon, Helen Weedon, Shawgi Sukumaran, Jennifer G Walker, Malcolm D Smith, Mihir D Wechalekar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Immune checkpoint inhibitors (ICIs) are associated with rheumatic and musculoskeletal immune-related adverse events (irAEs) in 5%–20% of patients. Currently, patients refractory to corticosteroids and conventional disease-modifying antir
Externí odkaz:
https://doaj.org/article/3ff420a1c1334dfdbe3137f84bc8f0e1
Publikováno v:
Nutrients, Vol 13, Iss 12, p 4557 (2021)
Dietary intake, specifically consumption of anti-inflammatory micronutrients, can play a role in both cancer initiation as well as the treatment-related outcomes experienced by patients receiving systemic cancer therapy. Increasing research is being
Externí odkaz:
https://doaj.org/article/de6bde4e62bb404e95b3feb369383e55
Autor:
Amitesh Chandra Roy, M. Nazim Abbas, Timothy Jay Price, Nimit Singhal, Sina Vatandoust, John Leung, Ganessan Kichenadasse, Bogda Koczwara, Shawgi Sukumaran, Rajiv Kumar, Richard Woodman, Alex Scott-Hoy, Christos Stelios Karapetis
Publikováno v:
Pancreas. 51:490-495
Nab-paclitaxel has radiosensitizing antitumor efficacy in pancreatic cancer. We aimed to establish maximum tolerated dose (MTD) of nab-paclitaxel with radiotherapy in unresectable locally advanced pancreatic cancer.In a phase I dose escalation trial
Publikováno v:
Nutrition reviews. 81(1)
ContextChronic inflammation, characterized by prolonged elevated inflammation markers, is linked to several chronic conditions. Diet can influence the levels of inflammation markers in the body.ObjectiveThe aim of this systematic review was to assess
Autor:
Amitesh Roy, Bogda Koczwara, Kunal Jain, Kelly R. Mead, Stephen Quinn, A. Ayoola, Alison Richards, Sina Vatandoust, David L. Gordon, Chris Karapetis, Ganessan Kichenadasse, Raghu Kumar, Shawgi Sukumaran, Y. Honda-Okubo
Publikováno v:
Supportive Care in Cancer. 28:5411-5417
Influenza virus infection has significant morbidity and mortality in patients with medical co-morbidities who are also immunosuppressed. The efficacy of the seasonal influenza vaccine has not been well studied in patients receiving chemotherapy. We a
Autor:
Myron Klevansky, Shawgi Sukumaran, Bogda Koczwara, Christos S. Karapetis, M. Nazim Abbas, Sina Vatandoust, Amitesh Roy
Publikováno v:
Cancer Reports. 5
Background Nivolumab improves disease control and survival in advanced NSCLC in patients with good performance status (PS), but there is limited data on its efficacy in patients with poor PS. Aim Primary objective of the study was to evaluate the eff
Autor:
Jamie E Craig, James Slattery, Amelia Craig, Mihir D. Wechalekar, Julia New-Tolley, Ella C. Berry, Sonja Klebe, Alannah Quinlivan, Shawgi Sukumaran, Owen M. Siggs, Sean Mullany
Publikováno v:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
Immune checkpoint inhibitor therapy is frequently associated with immune-related adverse events, which occasionally manifest with visual symptoms. Here, we describe a case of unilateral and sudden-onset painless vision loss in an 82-year-old man with
Autor:
Jeffrey A. Gelfand, D Osei Fofie, B. Framroze, A. Lategan, L A Jones, Shawgi Sukumaran, C.A. Connell, Victoria J Bray, P Y Song, G. Landers, P Habana, M. Dimitriu, J.A. Wetter, P A Kraus, Stephen T. Sonis, S Dalvie
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e376-e377
Purpose/objective(s) Oral Mucositis (OM) is a common, painful, and costly toxicity associated with cytotoxic chemoradiation regimens used to treat HN scores were centrally assigned. The primary efficacy endpoints included the incidence and duration o